Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19,981 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies.
Liu X, Park J, Xia S, Liang B, Yang S, Wang Y, Syrkina O, Lavis N, Liu S, Zhao C, Ding J, Hu J, Samson SI, de Bruijn IA; FSQ01 and FSQ02 Study Groups. Liu X, et al. Among authors: zhao c. Hum Vaccin Immunother. 2022 Nov 30;18(6):2132798. doi: 10.1080/21645515.2022.2132798. Epub 2022 Nov 3. Hum Vaccin Immunother. 2022. PMID: 36328438 Free PMC article. Clinical Trial.
Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial.
Chen J, Jiang F, Zhao C, Chai J, Li L, Guan Q, Li X, Wang F, Li A, Gao H, Wang M, Fu L, Nie F, Ling W, Deng H, Zhou L. Chen J, et al. Among authors: zhao c. Hum Vaccin Immunother. 2023 Aug 1;19(2):2245721. doi: 10.1080/21645515.2023.2245721. Hum Vaccin Immunother. 2023. PMID: 37587615 Free PMC article. Clinical Trial.
19,981 results
You have reached the last available page of results. Please see the User Guide for more information.